Boonton, NJ – January 9, 2014 – Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced that Timothy J. Saxon, Vice President of Business Development of Enteris BioPharma, will be presenting at the Biotech Showcase™ 2014 Conference being held in San Francisco January 13-15, 2014.
Among the topics to be discussed, Mr. Saxon will provide an overview of Enteris’ proprietary oral delivery technology platform and the development of orally delivered peptide and small molecule drugs.
Details of Enteris’ presentation are as follows:
Event: Biotech Showcase 2014 Conference
Date: Wednesday, January 15, 2014
Time: 9:30 am, PST
Location: Hearst Room, 4th Floor – Parc 55 Wyndham San Francisco Union Square Hotel
Enteris BioPharma, Inc. is a privately held, New Jersey-based biotechnology company offering innovative formulation solutions built around its proprietary drug delivery technologies. Enteris’ proprietary oral delivery technology has demonstrated a track record of success across a range of compounds and therapeutic indications and has also been the subject of numerous feasibility studies and active development programs, several of which are in advanced stages of clinical development. For more information on Enteris BioPharma and its proprietary oral delivery technology, please visit www.EnterisBioPharma.com.
|For Enteris BioPharma:||Media Contacts:|
|Jason Rando / Claire Sojda|
Tiberend Strategic Advisors, Inc.